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The neuroimmune system (i.e., the immune system and those
components of the nervous system that help regulate immune
responses), and in particular the innate immune system, play a
role in the development of addictions, including alcoholism,
particularly in the context of stressful situations. Certain cells of
the neuroimmune system are activated both by stress and by
environmental factors such as alcohol, resulting in the induction
of genes involved in innate immunity. one of the molecules
mediating this gene induction is a regulatory protein called
nuclear factor-κB, which activates many innate immune genes.
Innate immune gene induction in certain brain regions (e.g., the
frontal cortex), in turn, can disrupt decision making, which is a
characteristic of addiction to alcohol and other drugs. Likewise,
altered neuroimmune signaling processes are linked to alcohol-
induced negative affect and depression-like behaviors and also
regulate alcohol-drinking behavior. Moreover, the expression of
several genes and proteins involved in innate immunity is
enhanced in addicted people. Finally, specific variants of
multiple innate immune genes are associated with the genetic
risk for alcoholism in humans, further strengthening the
connection between increased brain innate immune gene
expression and alcohol addiction. KEY WORDS: Other drug
dependence; alcoholism; addiction; causes of alcohol and
other drug use; genetic factors; environmental factors;
neurobiology; neuroimmune system; immune system; innate
immune system; innate immune genes; immune function
genes; nuclear factor-κB; stress; decision making; depression
The nervous system and the immune system interactclosely to regulate the body’s immune responses, includ-ing inflammatory responses. Accordingly, the term 
“neuroimmune system” refers to the immune system and
those components of the nervous system that help regulate
immune responses and also encompasses the hormones and
other signaling molecules that convey signals between the
immune and nervous systems. Part of the neuroimmune 
system is the innate immune system—a network of cells and
the signaling molecules they release that are present from
birth and form the first line of the body’s defense system,
including such responses as inflammatory reactions. This
article summarizes the role that the neuroimmune system and
genes encoding components of the innate immune system
play in the development of addiction, including alcoholism.
Neuroimmune Signaling, Drug Abuse, and Stress
Neuroimmune signaling influences the responses and func-
tions of a variety of body systems, including the digestive
(i.e., enteric) system, sensory pathways, and the hormonal
axis known as the hypothalamic–pituitary–adrenal (HPA)
axis, which is involved in the body’s stress response and 
also plays a role in addiction to alcohol and other drugs
(AODs).1 Immune cells called monocytes and monocyte-
like cells in the brain (e.g., microglia) are sensitive key cells
involved in neuroimmune signaling. When the immune 
system is stimulated or tissue damage occurs, these cells go
through multiple stages of activation, which at the molecular
level are reflected by the activation of a cascade of innate
immune genes (Graeber 2010). These responses of the mono -
cytes and microglia involve the production and secretion 
of signaling molecules, including inflammation-promoting
(i.e., proinflammatory) cytokines and chemokines, such as
monocyte chemotactic protein (MCP)-1, tumor necrosis
factor α (TNFα), and interleukin 1b (IL1b). In the brain,
microglial activation contributes to the activation of another
type of cell called astroglia, or astrocytes, which, like
microglia, show multiple stages of neuroimmune activation.
In the microglia, the different stages of activation are accom-
panied by morphological changes. Thus, these cells change
from their resting state with multiple branches (i.e., the ram-
ified form) to a less branched, bushy morphology after mild
activation and a rounded morphology after strong activation
(i.e., when major brain cell death occurs). Chronic alcohol
treatment induces mild, bushy microglial activation as well
as mild astrocyte activation (see figure 1). 
Activated glia show increased production of a wide range
of proteins. For example, they produce and secrete increased
amounts of proteases as well as of proteins found in the
space between cells (i.e., extracellular matrix proteins). In
addition, they generate increased amounts of proteins called
toll-like receptors (TLRs) that play a role in alcohol-induced
depressed mood and negative emotions (see below) and
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1 Among the main molecules involved in the HPA system are the glucocorticoids (e.g., cortisol), 
and cycles of stress as well as AoD abuse lead to elevated basal glucocorticoid levels and promote
addiction (Armario 2010).
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show enhanced activity of enzymes known as oxidases that
promote inflammatory reactions (e.g., nicotinamide adenine
dinucleotide phosphate [NADPH] oxidases [NOX], cyclooxy-
genase [COX], and inducible nitric oxide synthases [iNOS]). 
Microglia easily can become activated, and the initial
stages of activation are characterized by the secretion of 
signaling molecules, slight morphological changes, and
increased production of molecules involved in immune
responses (i.e., major histocompatibility complex [MHC]) as
well as of TLRs (Graeber 2010). Activation of microglia and
astrocytes also increases proinflammatory agents, including
TNFa, that alter the transmission of nerve signals (i.e., neu-
rotransmission), including signal transmission mediated by
the excitatory neurotransmitter glutamate. Likewise, studies
have suggested that alcoholism is related to excessive gluta-
mate levels (i.e., a hyperglutamate state). In the outer layer of
the brain (i.e., the cerebral cortex), chronic alcohol-induced
neuroimmune activation leads to a hyperglutamate state that
reduces cortical function (figure 2). One mechanism con-
tributing to this hyperglutamate state involves TNFa, which
acts to reduce the activity of glutamate transporters2 in the
astrocytes (Zou and Crews 2005). Similarly,
beverage alcohol (i.e., ethanol) has been
shown to inhibit glutamate transport (Zou
and Crews 2006). This blockade of gluta-
mate transporters increases glutamate levels
outside the cells and particularly in the 
space between two neurons where nerve 
signals are transmitted (i.e., the synapse),
resulting in excessive neuronal activity (i.e.,
hyperexcitability). TNFa also stimulates 
the production of certain proteins found 
on signal-receiving neurons that interact
with glutamate (i.e., the AMPA glutamate
receptors) (Beattie et al. 2010). Increases in
synaptic glutamate receptors and glutamate
concentrations cause hyperexcitability that
disrupts the normal concentration of the
brain’s response to a specific area of the 
cortex (i.e., cortical focus), thereby reducing
cortical function. Through these mechanisms,
monocytes, microglia, and astrocytes pro-
gressively become activated by stress and
environmental factors, including ethanol,
resulting in the induction of genes that
encode proteins involved in the innate
immune response.
Stress and Drug Abuse Increase Transcription of
Innate Immune Genes 
Stress and AODs, as well as sensory and hormonal signals,
activate a regulatory protein (i.e., transcription factor3) called
nuclear factor k–light-chain enhancer of activated B cells
(NF-kB) that is produced in large amounts (i.e., is highly
expressed) in monocytes and microglia. Although NF-kB is
found in most cells, it is the key transcription factor involved
in the induction of innate immune genes in microglia and
other monocyte-like cells. A wide range of stimuli, such as
stress, cytokines, oxidative free radicals, ultraviolet irradiation,
bacterial or viral molecules, and many other signaling molecules,
increase binding of NF-kB to specific sequences of the DNA.
This binding increases the transcription of many genes, partic-
ularly those encoding signaling molecules (e.g., chemokines and
cytokines) and enzymes (e.g., oxidases and proteases) (figure 3).
Studies found that ethanol can increase the binding of NF-kB
to its corresponding DNA sequences both in the brains of liv-
ing organisms (Crews et al. 2006) and in cultured brain slices
obtained from a brain area called the hippocampal–entorhinal
Figure 1 Activation of microglia and astrocytes by alcohol in the brain. Microglia and
astrocytes undergo multiple stages of activation that include characteristic changes
in morphology. Resting microglia become ramified microglia with that express
molecules called major histocompatibility complex (MHC) on their surface.
Similarly, astrocytes begin to show markers of reactive astrocytes. Alcohol-
induced glial activation is associated with increased expression of innate
immune genes, including increased expression of the chemokine monocyte
chemoattractant protein-1 (MCP1); the cytokines tumor necrosis factor-a
(TNFa), interleukin-1 b (IL-1b) , and interleukin-6 (IL-6); the proteases matrix
metalloproteinase (MMP) and tissue plasminogen activator (TPA); and the 
oxidases nicotinamide adenine dinucleotide phosphate oxidase (NOX), cyclo-
oxygenase (COX), and nitric oxide synthetase (NOS). The alcohol-induced 
activation of glial innate immune genes increases neuronal hyperexcitability
(Crews et al. 2011).
2 Glutamate transporters are proteins that shuttle glutamate released by
nerve cells (i.e., neurons) into the space between cells back into the neuron;
this is essential to terminate transmission of a nerve signal and thus
ensure appropriate regulation of neuronal activity.
3 Transcription factors are proteins that are necessary for a set of reactions
called transcription, which is the first step of the process during which the
genetic information encoded in the DNA is used as a template for the gen-
eration of functional proteins.
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cortex (HEC) (Zou and Crews 2006). These and other studies
also have indicated that ethanol increases transcription of NF-
kB target genes, including the genes encoding the following:
• MCP-1;
• Certain proinflammatory cytokines, such as TNF, IL-
1, and IL-6;
• Certain proinflammatory oxidases, such as iNOS (Zou
and Crews 2010), COX-2 (Knapp and Crews 1999), and
NOX (Qin et al. 2008); and
• Certain proteases, such as TNF–converting enzyme (TACE)
and tissue plasminogen activator (Zou and Crews 2010).
Not only ethanol but also chronic stress increases brain
NF-kB activation (Koo et al. 2010; Madrigal et al. 2002), 
as well as the levels of cytokines, prostaglandin,4 and COX-2
(Madrigal et al. 2003), all of which have proinflammatory
effects. Although acute stress–induced responses, such as 
elevated glucocorticoid levels, are anti-inflammatory by
blocking NF-kB production, chronic elevation of glucocor-
ticoid levels during cycles of stress and/or AOD abuse
reverses these anti-inflammatory effects and indeed results 
in proinflammatory NF-kB activation in the frontal cortex
(Munhoz et al. 2010). Thus, activation of NF-kB is a com-
mon molecular mechanism through which stress and AODs
can induce innate immune genes. 
Addiction and Neuroimmune Signaling
Alcoholism is a progressive disease related to repeated episodes
of alcohol abuse that reduce the brain’s behavioral control and
decision-making ability; at the same time, increasing habitual
Figure 2 Mechanisms of alcohol-induced excessive glutamate activity in the cortex and loss of cortical focus. Ethanol-induced activation of
microglia and astrocytes increases the levels of proinflammatory cytokines, including tumor necrosis factor-alpha (TNF). (Left panel)
TNF creates a state characterized by excess activity of the neurotransmitter glutamate (i.e., a hyperglutamate state). Thus, TNF reduces
the levels of the primary glutamate transporters, GLT-1, in the astrocytes, in the cerebral cortex, and inhibits glutamate transport, possibly
through induction of TNF and other proinflammatory genes. As a result, glutamate levels outside the neurons, and particularly at the
synapse, increase, resulting in a hyperglutamate state. In addition, TNF increases the levels of certain molecules that interact with gluta-
mate (i.e., AMPA receptors). All these processes causes excessive neuronal excitability. (Right panel) Hyperexcitability disrupts cortical
focus. The left image shows the response of a normal adult auditory cortex to a series of tones with a frequence of 2-32 kHz colorized as
blue to red. The response to a specific tone involves activation of a specific focal cortical region, which likely relates to the ability to distin-
guish specific tones of sounds. The right image shows the disrupted hyperglutamate-state–like response to sound that involves the entire
auditory cortex without specific tonal areas of focus. The hyperglutatamate state increases cortical excitability, which in turn decreases
function because it results in loss of focal activation and likely loss of tonal discrimination. In alcoholism, the hyperglutamate state most
strongly affects the frontal cortex, which may disrupt decision making as well as attention and behavioral control mechanisms.
SOURCE: Image in right panel adapted from Chang and Merzenich (2003).
4 Prostaglandins are lipid compounds that are produced by almost all cells in the body and have a
variety of important physiological effects, including the regulation of inflammatory reactions.
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urges combined with increasing bad feelings (i.e., negative
affect) promote continued drinking. Frontal cortical brain
regions that designate attention and motivation, using infor-
mation to predict the result of actions (Schoenbaum and
Shaham 2008), play a role in addiction development. Frontal
cortical dysfunction often is investigated using reversal-learning
tasks. In reversal learning, the subject first learns to make one
choice (e.g., responding to the black objects in a series of black
and white objects) and then has to learn to reverse this choice
(e.g., to respond to the white objects). Thus, the initially expected
responses suddenly are considered wrong, requiring the subject
to exhibit flexible behavior in response to outcomes that do not
match those predicted by preceding cues (Stalnaker et al. 2009).
In behavioral studies, poor performance on such tasks is
supposed to reflect the inability of drug-addicted individuals
to learn new healthy behaviors and avoid the negative conse-
quences of their drug consumption. Such
learning and/or changes in behavior require
signals from the frontal cortex to indicate the
value of decisions. Studies found that binge
drinking induces persistent deficits in reversal
learning in rats (Obernier et al. 2002; Pascual
et al. 2007) and in adult mice following a
model of adolescent binge drinking (Coleman
2010). Other investigators similarly have
demonstrated that cocaine use results in
abnormally slow reversal learning, even
though initial learning is normal (Calu et al.
2007; Schoenbaum et al. 2004). Specifically,
human cocaine and alcohol addicts exhibit
dysfunctional decision making in reversal-
learning tasks that probe cognitive flexibility
(Bechara et al. 2002). Lesions in the frontal
cortex cause reversal-learning deficits compa-
rable to those induced by chronic drug abuse
(Schoenbaum et al. 2006). The persistence
of addiction matches the persistent increases
in innate immune gene activation (Qin et al.
2007, 2008) and loss of behavioral flexibility.
Thus, it is thought that innate immune gene
induction in the frontal cortex disrupts decision
making consistent with addiction (Crews et
al. 2011). 
Addiction to alcohol, opiates, and stimulant
drugs involves both changes in attention–
decision making and increased temporal
lobe anxiety–negative affect urgency.
Addiction-induced negative affect and
depression-like behaviors also are linked to
neuroimmune signaling because neuroim-
mune signals can alter moods. For example,
a compound called lipopolysaccharide (LPS)
that can induce brain innate immune genes
causes depression-like behavior that mimics
components of addiction-like negative affect.
LPS naturally binds with one of the TLRs
(i.e., TLR4) and this interaction results in
NF-kB activation, ultimately leading to the induction of
innate immune genes. In humans, LPS infusions reduce
reward responses and increase depressed mood (Eisenberger
et al. 2010). Likewise, when patients with cancer or viral
infections are treated with agents such as interferon and IL
that influence innate immune genes, they may experience
severe depression as a major adverse effect (Kelley and
Dantzer 2011). Innate immune activators such as LPS,
chemokines, and cytokines can mimic the amplification of
depressed mood that occurs during repeated cycles of drug
abuse or stress (Breese et al. 2008). All of these observations
further support the link between neuroimmune signaling
and mood as well as the role of neuroimmune signaling as a
key component of addiction neurobiology. Of interest,
chronic alcohol leads to withdrawal anxiety in normal mice
Figure 3 Innate immune gene polymorphisms associated with risk for alcoholism. The
schematic shows a representative astrocyte or microglial cell. Genes associated
with genetic risk for alcoholism are in light blue. Nuclear factor k-lightchain–
enhancer of activated B cells (NF-kB) is a key transcription factor involved in
induction of innate immune genes that is sensitive to reactive oxygen species
(ROS). These ROS are generated by the enzyme CYP2E1 during alcohol
metabolism, and certain DNA sequences (i.e., polymorphisms) in the CYP2E1
gene are associated with alcoholism. CYP2E1 is highly expressed in monocyte-
like cells, which are activated when CYP2E1 metabolizes alcohol. The ROS
formed during this process activate proinflammatory NF-kB responses. Chronic
ethanol treatment increases CYP2E1 expression in the brain, particularly in
astrocytes.The resulting elevated ROS levels activate NF-kB–mediated tran-
scription of innate immune genes, and this response may be amplified in the
presence of certain NF-kB polymorphisms (i.e., NF-kB1). Certain variants of
other genes also are associated with alcoholism, including polymorphisms of 
T NFa, interleukin-10 (IL-10), interleukin-1 receptor antagonist (IL-1RA), and
other components of the IL-1 gene complex, as well as of certain proteins in
the space surrounding the cells (i.e., extracellular matrix proteins [ECM]).
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tent with the hypothesis that innate immune activation drives
negative affect and associated anxiety responses. Thus, the
anxiety–depression negative affect that contributes to addic-
tion occurs with increased brain neuroimmune signaling.
Neuroimmune signaling also regulates alcohol drinking
behavior. Genetic comparisons among different strains of
rats and mice found that addiction-like drinking behavior
was associated with increased levels or activity of NF-κ B, 
its regulatory proteins, and multiple innate immune genes
(Mulligan et al. 2006). Furthermore, induction of innate
immune genes resulted in increased ethanol consumption,
whereas inactivation of such genes reduced drinking behav-
ior (Blednov et al. 2005, 2011b). Thus, across genetically
divergent strains of mice, innate immune responses to LPS
corresponded to increases in ethanol consumption (Blednov
et al. 2005, 2011b). In fact, even a single injection of LPS
was able to produce a long-lasting increase in ethanol con-
sumption (Blednov et al. 2011a) that corresponded to sustained
increases in brain innate immune gene expression (Qin et 
al. 2007). These studies identified several innate immune
molecules (e.g., b2 -microglobulin, cathepsins, and CD14, 
a key innate immune signaling protein) as important for reg-
ulating drinking behavior. Thus, innate immune gene induc-
tion may underlie the progressive loss of behavioral flexibility,
increasing negative affect, and increased alcohol drinking asso-
ciated with repeat episodes of alcohol abuse and alcoholism. 
Activity of Innate Immune genes Is Increased 
in the Addicted Brain
Direct analyses of changes in the activity or levels of various
proteins in the brains of alcoholics and other drug addicts
also can provide insight into the neurobiology of addiction.
Such studies found the following:
• Postmortem studies of the brains of human alcoholics
indicate that the innate immune chemokine MCP-1 is
increased severalfold in multiple brain regions (Breese et
al. 2008). Consistent with this, chronic alcohol treatment
of mice (Qin et al. 2008) or of cultured brain slices from
the rat hippocampus (Zou and Crews 2010) also increases
expression of MCP-1 and other innate immune genes.
• Proteins that serve as markers of microglial activation are
increased across the alcoholic brain (He and Crews 2008). 
• Consistent with alcoholism being related to neuroim-
mune signaling, postmortem studies of gene expression in
the brains of human alcoholics found increased levels of 
a subunit of NF-κB; moreover, 479 genes targeted by
NF-κB showed increased expression in the frontal cortex
of alcoholics (Okvist et al. 2007). 
• Postmortem analyses of alcoholic human brain gene
expression found innate immune activation of cell adhe-
sion and extracellular membrane components of innate
immune gene signaling (Liu et al. 2006). 
Thus, the findings of several studies of gene or protein
expression are consistent with increased neuroimmune sig-
naling in the brains of addicted individuals.
Polymorphisms of Innate Immune genes and
genetic risk of Addiction 
Genetic factors account for approximately 50 percent of the
risk of alcohol dependence (Schuckit 2009). Multiple genes
linked to innate immune function also have been linked to
the risk for alcoholism (see figure 3). DNA variations (i.e.,
polymorphisms) at specific locations on the chromosomes
result in gene variants (i.e., alleles) that differ in their func-
tion or activity and thereby may increase or reduce the risk
of alcoholism. For example, polymorphisms in the gene
encoding an enzyme called CYP2E1, which is involved in
ethanol metabolism, have been associated with the risk for
alcoholism (Webb et al. 2010). In the body, CYP2E1 is
highly expressed in monocyte-like cells; ethanol metabolism
by CYP2E1 leads to the activation of these cells. Specifically,
CYP2E1-mediated ethanol metabolism causes an increased
production of highly reactive molecules called reactive oxy-
gen species (ROS) within the monocytes that activate proin-
flammatory NF-κB responses (Cao et al. 2005) (see figure 3).
In the brain, ethanol exposure leads to increased CYP2E1
expression, particularly in astrocytes (Montoliu et al. 1994,
1995), which likely contributes to astrocyte activation of
NF-κB transcription during chronic alcohol exposure. 
Human genetic association studies also have directly
linked certain polymorphisms of the genes encoding NF-κB
to alcohol dependence (Edenberg et al. 2008; Flatscher-Bader
et al. 2005; Okvist et al. 2007). For example, polymorphisms
in a precursor gene called NF-kB1 that encodes one of the
subunits of the transcription factor (i.e., the NF-κB p50
subunit) and which is important for activation of transcription
have been associated with the risk for alcoholism (Edenberg
et al. 2008). Likewise, alleles of the proinflammatory cytokine
TNFα that result in increased TNFα expression have been
linked to alcoholism and alcoholic liver disease (Pastor et al.
2000, 2005; Powell et al. 2000). Another genetic linkage
exists between certain alleles of the anti-inflammatory, NF-
κB–inhibiting cytokine IL-10 and alcoholism (Marcos et al.
2008). Additional genetic evidence regarding innate immune
genes and the risk for alcoholism comes from polymorphisms
of the gene encoding a molecule called the IL-1 receptor
antagonist as well as from multiple other alleles of the IL-1
gene complex (Saiz et al. 2009).
In general, gene polymorphisms associated with increased
risk of alcoholism tend to increase proinflammatory responses.
For example, alcohol exposure may increase the expression 
of proinflammatory cytokines or individuals at risk of alcohol
dependence may carry alleles associated with decreased anti-
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inflammatory cytokine secretion. Thus, multiple innate
immune gene polymorphisms are associated with genetic
risk for alcoholism in humans, consistent with the assump-
tion that increased brain innate immune gene expression
contributes to the neurobiology of alcohol addiction.
Summary
The findings summarized in this article link innate immune
gene induction to addiction and alcoholism. Monocytes,
microglia, and astrocytes are sensitive to AODs and stress,
with repeated AOD use causing progressive innate immune
gene induction that parallels changes in decision making,
mood, and alcohol consumption. Stress and AODs activate
NF-κB transcription in the brain, which in turn enhances
expression of proinflammatory NF-κB target genes. As a result,
molecules related to the innate immune response, such as
the chemokine MCP-1, the proinflammatory cytokines
TNFα, IL-1β, and IL-6; the proinflammatory oxidases iNOS,
COX, and NOX (Qin et al. 2008); and proinflammatory
proteases are found following chronic ethanol treatment.
Postmortem analyses of human alcoholic brain also have
demonstrated increased expression of innate immune genes,
which can disrupt cognition, mood, and drug consumption
and is consistent with addition-like behavior. Finally, poly-
morphisms of genes involved in the innate immune responses
influence the risk for alcoholism. These studies suggest that
innate immune genes contribute to alcoholism and may be
involved in the genetic risk for alcoholism.  ■
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